Related by context. Frequent words. (Click for all words.) 61 retrospective cohort study 57 Surveillance Epidemiology 57 Arch Intern Med 56 NHANES III 56 carotid stenosis 55 End Results SEER 54 prospectively defined 54 Response Evaluation Criteria 54 metastatic lung cancer 54 confidence interval #.#-#.# 54 Nationwide Inpatient Sample 54 Gynecologic Oncology Group 53 sensitivity specificity 53 % CI #.#-#.# [003] 53 substudy 53 poor metabolizers 53 HSCT 53 retrospectively reviewed 52 Percutaneous Coronary Intervention 52 RRMS patients 52 Prostate Cancer Prevention 52 univariate 52 biochemical recurrence 52 Gastrointestinal Cancers Symposium 52 NSABP 51 malignant pleural mesothelioma 51 J Clin Oncol 51 colorectal adenomas 51 N Engl J 51 SABCS 51 subanalysis 51 Antihypertensive 51 mRCC 51 multivariate analyzes 51 sustained virologic response 51 fluvastatin 51 median CD4 51 KRAS wild 51 advanced adenomas 51 histopathologic 51 FOLFOX4 50 % CI #.#-#.# [007] 50 RECIST criteria 50 CI #.#-#.# [002] 50 evaluable patients 50 nonmelanoma skin cancer 50 liver transplant recipients 50 RTOG 50 Epidemiologic 50 Kaplan Meier 50 adjuvant radiation 50 Multicenter 50 coronary revascularization 50 QTc prolongation 50 annualized relapse 50 evaluable 50 BRFSS 50 immunohistochemical 50 vertebral fracture 50 erythrocyte sedimentation rate 50 glomerular filtration rate 50 vismodegib 50 Cancer Registry 50 haematological 50 randomized controlled clinical trials 49 XIENCE V demonstrated 49 nonmalignant 49 Solid Tumors 49 serologic 49 estimated glomerular filtration 49 prospective cohort 49 Recurrence Score 49 Acute Myocardial Infarction 49 MERLIN TIMI 49 #:#-# [031] 49 statistically significant p = 49 prespecified 49 prospective observational 49 patients evaluable 49 Medical Expenditure Panel 49 neoadjuvant 49 distant metastasis 49 squamous 49 mycophenolate mofetil 49 MGUS 49 Diabetologia 49 phase Ib 49 complete cytogenetic 49 placebo controlled clinical trials 48 Venous Thromboembolism 48 prevalences 48 refractory chronic lymphocytic 48 digital rectal examination 48 seroprotection 48 surrogate markers 48 prospective multicenter 48 thromboembolic 48 concomitant medications 48 virologic failure 48 colorectal cancer CRC 48 virological failure